Hochschulschrift
Multiplex in vitro and in vivo RNAi screening to identify treatment response modifiers of targeted therapies in HCC
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
30 cm
- Umfang
-
124 S.
- Sprache
-
Englisch
- Anmerkungen
-
Ill., graph. Darst.
Braunschweig, Techn. Univ., Diss., 2014
- Klassifikation
-
Medizin, Gesundheit
Biowissenschaften, Biologie
- Urheber
-
Rudalska, Ramona Paulina
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 13:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Rudalska, Ramona Paulina
Ähnliche Objekte (12)
Multiplex in vitro and in vivo RNAi screening to identify treatment response modifiers of targeted therapies in HCC
Novel RNAi-Based Therapies for Atherosclerosis
Modifiers of notch transcriptional activity identified by genome-wide RNAi
A Genome-Wide RNAi Screen for Modifiers of Polyglutamine-Induced Neurotoxicity in Drosophila
Identification of modifiers of cellular viability and TRAIL-induced apoptosis using genome-wide RNAi screens
A large-scale RNAi-based screen for modifiers of FUS-induced neurotoxicity in Drosophila melanogaster
A Genome-Wide Screen on Modifiers of Tau-Induced Neurodegeneration Using RNAi-Mediated Gene Silencing in Drosophila
RNAi to treat SARS‐CoV‐2—variant proofing the next generation of therapies
Lipid Nanoparticle (LNP) ‐A Vector Suitable for Evolving Therapies for Advanced Hepatocellular Carcinoma (HCC)
HccB!
"HccB
HccB
Multiplex in vitro and in vivo RNAi screening to identify treatment response modifiers of targeted therapies in HCC
Novel RNAi-Based Therapies for Atherosclerosis
Modifiers of notch transcriptional activity identified by genome-wide RNAi
A Genome-Wide RNAi Screen for Modifiers of Polyglutamine-Induced Neurotoxicity in Drosophila
Identification of modifiers of cellular viability and TRAIL-induced apoptosis using genome-wide RNAi screens
A large-scale RNAi-based screen for modifiers of FUS-induced neurotoxicity in Drosophila melanogaster
A Genome-Wide Screen on Modifiers of Tau-Induced Neurodegeneration Using RNAi-Mediated Gene Silencing in Drosophila
RNAi to treat SARS‐CoV‐2—variant proofing the next generation of therapies
Lipid Nanoparticle (LNP) ‐A Vector Suitable for Evolving Therapies for Advanced Hepatocellular Carcinoma (HCC)
HccB!
"HccB
HccB
Multiplex in vitro and in vivo RNAi screening to identify treatment response modifiers of targeted therapies in HCC
Novel RNAi-Based Therapies for Atherosclerosis
Modifiers of notch transcriptional activity identified by genome-wide RNAi
A Genome-Wide RNAi Screen for Modifiers of Polyglutamine-Induced Neurotoxicity in Drosophila
Identification of modifiers of cellular viability and TRAIL-induced apoptosis using genome-wide RNAi screens
A large-scale RNAi-based screen for modifiers of FUS-induced neurotoxicity in Drosophila melanogaster
A Genome-Wide Screen on Modifiers of Tau-Induced Neurodegeneration Using RNAi-Mediated Gene Silencing in Drosophila
RNAi to treat SARS‐CoV‐2—variant proofing the next generation of therapies
Lipid Nanoparticle (LNP) ‐A Vector Suitable for Evolving Therapies for Advanced Hepatocellular Carcinoma (HCC)
HccB!
"HccB